Hot Products

Licopyranocoumarin
Catalog No: CFN92918

Licopyranocoumarin could as a potent neuroprotective drug via markedly blocked MPP+-induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK.
Licoricesaponin A3
Catalog No: CFN92923

Licoricesaponin A3 shows the cytotoxic activity against the human cancer cell lines MGC-803, SW620, and SMMC-7721 with IC50 > 100 μmol/L.
Licoricesaponin E2
Catalog No: CFN92912

Licoricesaponin E2 displayed the inhibition on the growth of cancer cells with IC50 at 18.3-41.6 umol/L, it could significantly increase the cytotoxic activity after hydrolysis.
Licoricesaponin G2
Catalog No: CFN92915

Licoricesaponin G2 has the anti-inflammatory effects as NF-κB inhibitors, it has anti-HIV activity via significantly interacted with R15K.
Licoricesaponin H2
Catalog No: CFN95173

Reference standards.
Licoricidin
Catalog No: CFN96389

Licoricidin, is a potent anti-metastatic agent, which can markedly inhibit the metastatic and invasive capacity of malignant prostate cancer cells. Licoricidin and licorisoflavan A are effective in inhibiting the growth of all three bacterial species(Porphyromonas gingivalis, Prevotella intermedia and Solobacterium moorei), with minimal inhibitory concentrations in the range of 2-80 ug /ml, they have a potential for reducing bacterial volatile sulfur compounds (VSCs) production and therefore for controlling halitosis; they also have potential for the development of novel host-modulating strategies for the treatment of cytokine and/or MMP-mediated disorders such as periodontitis. Licoricidin may be considered as an active ingredient in new topically applied anti-ageing formulations, it blocks UVA-induced photoaging via ROS scavenging,this activity converges to limit the activity of MMP-1.
Licoricone
Catalog No: CFN96504

Licoricone exhibits anti-helicobacter pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains.
Licraside
Catalog No: CFN91792

Licraside(licuraside) has potency and ability to inhibit mushroom tyrosinase monophenolase activity with an IC(50) value of 0.072 mM. Licraside(Licurazid) has anticancer properties.
Liensinine
Catalog No: CFN99580

Liensinine is a human ether-a-go-go-related gene (hERG) inhibitor and a novel autophagy/mitophagy inhibitor, which can antagonize the ventricular arrhythmias. It exerts remarkable effect against thrombosis and possesses strong effect against platelet aggregation and coagulation.
Liensinine perchlorate
Catalog No: CFN99578

Liensinine perchlorate has inhibitory effect on macrophage phagocytosis and macrophage metabolism in mice, suggests that it has immunosuppressive effects.